Sulfamethoxazole: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 22: | Line 22: | ||
{{stub}} | {{stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
== Sulfamethoxazole == | |||
<gallery> | |||
File:Sulfamethoxazole-skeletal.svg|Sulfamethoxazole skeletal structure | |||
File:Sulfamethoxazole-from-xtal-3D-bs-17.png|3D structure of Sulfamethoxazole from crystal data | |||
File:THFsynthesispathway.png|Tetrahydrofolate synthesis pathway | |||
</gallery> | |||
Latest revision as of 03:49, 18 February 2025
Sulfamethoxazole is an antibiotic that is used in combination with trimethoprim, a dihydrofolate reductase inhibitor, to treat or prevent a variety of bacterial infections. It belongs to the class of sulfonamide antibiotics and works by inhibiting the growth of bacteria.
Medical uses[edit]
Sulfamethoxazole is used to treat a variety of bacterial infections, including urinary tract infections, bronchitis, and ear infections. It is also used to prevent Pneumocystis pneumonia in people with weakened immune systems.
Side effects[edit]
Common side effects of sulfamethoxazole include nausea, vomiting, loss of appetite, and skin rash. More serious side effects may include anemia, allergic reactions, and Stevens-Johnson syndrome.
Mechanism of action[edit]
Sulfamethoxazole works by inhibiting the synthesis of folic acid in bacteria, which is necessary for the production of DNA and proteins. It does this by competing with para-aminobenzoic acid (PABA) for the enzyme dihydropteroate synthase, thereby inhibiting the conversion of PABA to dihydrofolic acid.
History[edit]
Sulfamethoxazole was first synthesized in the 1960s and has since become a commonly used antibiotic for a variety of bacterial infections.



